Lactation Fortification Study
Impact of Nutrient Supplementation on Breast Milk Levels of Lactating Women
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46256
- Northpoint Pediatrics, LLC
-
-
Ohio
-
Dayton, Ohio, United States, 45414
- Ohio Pediatric Research Association, Inc
-
Kettering, Ohio, United States, 45420
- Ohio Pediatric Research Association, Inc
-
Mayfield Heights, Ohio, United States, 44124
- Institute of Clinical Research
-
Parma, Ohio, United States, 44129
- The Cleveland Pediatric Research Center, LLC
-
Westlake, Ohio, United States, 44145
- The Cleveland Pediatric Research Center, LLC
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Subjects will be eligible for the study if they meet all of the following inclusion criteria:
- Mother with singleton birth, 37-42 weeks gestation and ≥ 2490g
- Pre-pregnancy BMI </= 30
- Mother is ≥ 18 years of age
- Mother is 4-6 weeks postpartum and has been successfully continuously lactating
- Mother agrees to abstain from the use of any Docosahexaenoic acid (DHA), lutein and/or vitamin E containing supplements for at least 10 days prior to providing a baseline breast milk sample
- Mother agrees to abstain from the use of non-study supplements throughout the study
- Mother plans to continue breastfeeding for at least 6 weeks from the start of the study
- No significant ongoing medical problems in the infant as determined from infant's medical history as related by the parent(s) to the enrolling center personnel
Exclusion Criteria:
Subjects will be excluded from the study if they meet any of the following criteria:
- Subject had adverse maternal and/or fetal medical history
- Subject is participating in a non-Abbott approved concomitant trial
- Mother is taking cholesterol medication and/or medication affecting lipid absorption and/or transport
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Control Supplement
soft-gel placebo capsules, 2 capsules from the placebo bottle per day
|
Two capsules per day for the Placebo Group; One capsule per day for the Experimental Group A
|
|
Experimental: Experimental Supplement A
soft-gel capsules; 1 capsule from the experimental bottle and 1 capsule from the placebo bottle per day
|
Two capsules per day for the Placebo Group; One capsule per day for the Experimental Group A
One capsule per day for Experimental Supplement A Group; Two capsules per day for Experimental Supplement B Group
|
|
Experimental: Experimental Supplement B
soft-gel capsules; 2 capsules from the experimental bottle per day
|
One capsule per day for Experimental Supplement A Group; Two capsules per day for Experimental Supplement B Group
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Breast milk concentration of carotenoids
Time Frame: 1 - 43 days
|
1 - 43 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Breast milk concentration of fatty acids
Time Frame: 1 - 43 days
|
1 - 43 days
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood levels of nutrients and fatty acids
Time Frame: 1 and 43 days
|
In mothers at 1 and 43 days In infants at 43 days
|
1 and 43 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Christina Sherry, PhD, RD, Abbott Nutrition
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- AL05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.